Search Results - "Marco Roffi, MD"

Recurrent Vasospastic Myocardial Infarctions and Hand Necrosis by Rey, Florian, MD, Roffi, Marco, MD, Bouvet, Cindy, MD, Bréguet, Romain, MD, Jandus, Peter, MD, Rigamonti, Fabio, MD

Get full text

Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates by Valgimigli, Marco, MD, PhD, Patialiakas, Athanasios, MD, Thury, Attila, MD, PhD, McFadden, Eugene, MD, Colangelo, Salvatore, MD, Campo, Gianluca, MD, Tebaldi, Matteo, MD, Ungi, Imre, MD, PhD, Tondi, Stefano, MD, Roffi, Marco, MD, Menozzi, Alberto, MD, PhD, de Cesare, Nicoletta, MD, Garbo, Roberto, MD, Meliga, Emanuele, MD, Testa, Luca, MD, PhD, Gabriel, Henrique Mesquita, MD, Airoldi, Flavio, MD, Ferlini, Marco, MD, Liistro, Francesco, MD, Dellavalle, Antonio, MD, Vranckx, Pascal, MD, PhD, Briguori, Carlo, MD, PhD

“…Abstract Background The use of drug-eluting stents (DES) in patients at high risk of bleeding or thrombosis has not been prospectively studied; limited data…”
Get full text

Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention? by Ariotti, Sara, MD, Adamo, Marianna, MD, Costa, Francesco, MD, Patialiakas, Athanasios, MD, Briguori, Carlo, MD, PhD, Thury, Attila, MD, PhD, Colangelo, Salvatore, MD, Campo, Gianluca, MD, Tebaldi, Matteo, MD, Ungi, Imre, MD, PhD, Tondi, Stefano, MD, Roffi, Marco, MD, Menozzi, Alberto, MD, PhD, de Cesare, Nicoletta, MD, Garbo, Roberto, MD, Meliga, Emanuele, MD, Testa, Luca, MD, PhD, Gabriel, Henrique Mesquita, MD, Ferlini, Marco, MD, Vranckx, Pascal, MD, PhD, Valgimigli, Marco, MD, PhD

“…Abstract Objectives This study sought to investigate the ischemic and bleeding outcomes of patients fulfilling high bleeding risk (HBR) criteria who were…”
Get full text

Comparison of Newer-Generation Drug-Eluting With Bare-Metal Stents in Patients With Acute ST-Segment Elevation Myocardial Infarction by Sabaté, Manel, MD, PhD, Räber, Lorenz, MD, Heg, Dik, PhD, Brugaletta, Salvatore, MD, PhD, Kelbaek, Henning, MD, PhD, Cequier, Angel, MD, PhD, Ostojic, Miodrag, MD, PhD, Iñiguez, Andrés, MD, PhD, Tüller, David, MD, PhD, Serra, Antonio, MD, Baumbach, Andreas, MD, PhD, von Birgelen, Clemens, MD, PhD, Hernandez-Antolin, Rosana, MD, PhD, Roffi, Marco, MD, PhD, Mainar, Vicente, MD, Valgimigli, Marco, MD, PhD, Serruys, Patrick W., MD, PhD, Jüni, Peter, MD, Windecker, Stephan, MD

“…Objectives This study sought to study the efficacy and safety of newer-generation drug-eluting stents (DES) compared with bare-metal stents (BMS) in an…”
Get full text

Newer Generation Drug-Eluting Stents for Revascularization of Chronic Total Occlusions by Räber, Lorenz, MD, PhD, Roffi, Marco, MD

“…Corresponding Author…”
Get full text

Embolization to Two Different Vascular Territories in a Patient With Bicuspid Aortic Stenosis Undergoing Transcatheter Aortic Valve ImplantationNovel Teaching Points by Murat Cimci, MD, Marco Roffi, MD, Stephane Noble, MD

“…We describe the case of an 81-year-old man with symptomatic severe bicuspid aortic valve stenosis. Transfemoral transcatheter aortic valve implantation was…”
Get full text

Pressure Curve Measurements During Transcatheter Aortic Valve Implantation: A Useful Tool to Assess the Severity of Aortic Regurgitation by Noble, Stephane, MD, Roffi, Marco, MD

Get full text

Impact of Patient and Lesion Complexity on Long-Term Outcomes Following Coronary Revascularization with New-Generation Drug-Eluting Stents by Koskinas, Konstantinos C., MD, Taniwaki, Masanori, MD, Rigamonti, Fabio, MD, Heg, Dik, PhD, Roffi, Marco, MD, Tüller, David, MD, Muller, Olivier, MD, Vuillomenet, Andre, MD, Cook, Stephane, MD, Weilenmann, Daniel, MD, Kaiser, Christopher, MD, Jamshidi, Peiman, MD, Jüni, Peter, MD, Windecker, Stephan, MD, Pilgrim, Thomas, MD

“…Abstract Long-term clinical outcomes of new-generation drug-eluting stents in complex anatomic and clinical settings are not well defined. This study assessed…”
Get full text

Meta-Analysis of Randomized Trials of Postconditioning in ST-Elevation Myocardial Infarction by Favaretto, Enrico, MD, PhD, Roffi, Marco, MD, Frigo, Anna C., MSc, Lee, Michael S., MD, PhD, Marra, Martina P., MD, PhD, Napodano, Massimo, MD, Tarantini, Giuseppe, MD, PhD

“…Clinical benefit of postconditioning in patients with ST-elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention is still…”
Get full text

Randomized comparison of biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for percutaneous coronary revascularization: Rationale and design of the BIOSCIENCE trial by Pilgrim, Thomas, MD, Roffi, Marco, MD, Tüller, David, MD, Muller, Olivier, MD, Vuilliomenet, André, MD, Cook, Stéphane, MD, Weilenmann, Daniel, MD, Kaiser, Christoph, MD, Jamshidi, Peiman, MD, Heg, Dik, PhD, Jüni, Peter, MD, Windecker, Stephan, MD

“…Background Biodegradable polymers for release of antiproliferative drugs from metallic drug-eluting stents aim to improve long-term vascular healing and…”
Get full text

Angioplasty and Provisional Stent Treatment of Common Femoral Artery Lesions by Bonvini, Robert F., MD, Rastan, Aljoscha, MD, Sixt, Sebastian, MD, Beschorner, Ulrich, MD, Noory, Elias, MD, Schwarz, Thomas, MD, Roffi, Marco, MD, Dorsaz, Pierre-André, PhD, Schwarzwälder, Uwe, MD, Bürgelin, Karlheinz, MD, Macharzina, Roland, MD, Zeller, Thomas, MD

“…Abstract Purpose Isolated atherosclerotic common femoral artery (CFA) disease is a rare cause of symptomatic peripheral arterial disease. Although surgical…”
Get full text

Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: Rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint stent in Uncertain DES Candidates study by Valgimigli, Marco, MD, PhD, Patialiakas, Athanasios, MD, Thury, Attila, MD, PhD, Colangelo, Salvatore, MD, Campo, Gianluca, MD, Tebaldi, Matteo, MD, Ungi, Imre, MD, PhD, Tondi, Stefano, MD, Roffi, Marco, MD, Menozzi, Alberto, MD, PhD, de Cesare, Nicoletta, MD, Garbo, Roberto, MD, Meliga, Emanuele, MD, Testa, Luca, MD, PhD, Gabriel, Henrique M., MD, Airoldi, Flavio, MD, Ferlini, Marco, MD, Liistro, Francesco, MD, Dellavalle, Antonio, MD, Vranckx, Pascal, MD, Briguori, Carlo, MD, PhD

“…Background The use of drug-eluting stent (DES) instead of bare-metal stent (BMS) in patients at high stent thrombosis or bleeding risk as well as in those at…”
Get full text

Current role of emboli protection devices in percutaneous coronary and vascular interventions by Roffi, Marco, MD, Mukherjee, Debabrata, MD

“…After the observation that distal embolization is a frequent complication of coronary and vascular interventions, mechanical emboli protection devices (EPD)…”
Get full text

Angiojet Rheolytic Thrombectomy in Massive Pulmonary Embolism: Locally Efficacious but Systemically Deleterious? by Bonvini, Robert F., MD, Righini, Marc, MD, Roffi, Marco, MD

Get full text

Diabetes and acute coronary syndromes by Roffi, Marco, MD, Eberli, Franz R., MD

“…Diabetic patients with acute coronary syndromes (ACSs) are at a high risk for subsequent cardiovascular events but derive, at the same time, greater benefit…”
Get full text

Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute ST-Segment Elevation Myocardial Infarction by Piccolo, Raffaele, MD, Heg, Dik, PhD, Franzone, Anna, MD, Roffi, Marco, MD, Tüller, David, MD, Vuilliomenet, André, MD, Muller, Olivier, MD, Cook, Stéphane, MD, Weilenmann, Daniel, MD, Kaiser, Christoph, MD, Jamshidi, Peiman, MD, Iglesias, Juan F., MD, Windecker, Stephan, MD, Pilgrim, Thomas, MD

Get full text

Rapid Progression of Left Main Coronary Disease Causing Acute Coronary Syndrome by Cherian, Sanjay, MD, PhD, Roffi, Marco, MD, Kalangos, Afksendiyos, MD, PhD, Cikirikcioglu, Mustafa, MD, PhD

Get full text

Late Tamponade Secondary to Aortic Root Perforation by BioSTAR Septal Closure Device by Cikirikcioglu, Mustafa, MD, PhD, Cherian, Sanjay, MD, PhD, Lerch, Rene, MD, Licker, Marc-Joseph, MD, Roffi, Marco, MD, Bonvini, Robert F., MD, Kalangos, Afksendiyos, MD, PhD

“…We report a patient who presented with pericardial tamponade 9 months after percutaneous closure of a patent foramen ovale using a BioSTAR septal closure…”
Get full text

Percutaneous noncoronary interventions during continuous mechanical chest compression with the LUCAS-2 device by Park, Chan-il, MD, Roffi, Marco, MD, Bendjelid, Karim, MD, PhD, Bonvini, Robert F., MD

Get full text

Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention by Räber, Lorenz, MD, PhD, Klingenberg, Roland, MD, Heg, Dik, PhD, Kelbæk, Henning, MD, Roffi, Marco, MD, Tüller, David, MD, Baumbach, Andreas, MD, Zanchin, Thomas, MD, Carballo, David, MD, Ostojic, Miodrag, MD, PhD, Stefanini, Giulio G., MD, PhD, Rodondi, Nicolas, MD, von Birgelen, Clemens, MD, PhD, Moschovitis, Aris, MD, Engstrøm, Thomas, MD, Gencer, Baris, MD, Auer, Reto, MD, Meier, Bernhard, MD, Mach, Francois, MD, Lüscher, Thomas F., MD, Jüni, Peter, MD, Matter, Christian M., MD, Windecker, Stephan, MD

“…Abstract Objectives The aim of this study was to assess the safety of the concurrent administration of a clopidogrel and prasugrel loading dose in patients…”
Get full text